Pfizer Inc PFE:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD

After Hours: Last | 6:09 PM EDT

27.80

-0.01 (-0.04%)

Volume

27,563,762

27.81

+0.11 (+0.40%)

Volume

32,563,537

52 week range

25.20 - 40.37

Open27.86
Day High27.91
Day Low27.52
Prev Close27.70
52 Week High40.37
52 Week High Date06/13/23
52 Week Low25.20
52 Week Low Date04/26/24

Key Stats

Market Cap157.475B
Shares Out5.66B
10 Day Average Volume46.39M
Dividend1.68
Dividend Yield6.04%
Beta0.65
YTD % Change-3.4

KEY STATS

Open27.86
Day High27.91
Day Low27.52
Prev Close27.70
52 Week High40.37
52 Week High Date06/13/23
52 Week Low25.20
52 Week Low Date04/26/24
Market Cap157.475B
Shares Out5.66B
10 Day Average Volume46.39M
Dividend1.68
Dividend Yield6.04%
Beta0.65
YTD % Change-3.4

RATIOS/PROFITABILITY

EPS (TTM)-0.06
P/E (TTM)-457.40
Fwd P/E (NTM)13.25
EBITDA (TTM)16.737B
ROE (TTM)2.31%
Revenue (TTM)55.093B
Gross Margin (TTM)70.45%
Net Margin (TTM)-0.46%
Debt To Equity (MRQ)80.76%

EVENTS

Earnings Date07/30/2024(est)
Ex Div Date05/09/2024
Div Amount0.42
Split Date-
Split Factor-

Latest On Pfizer Inc

Interest rates and the AI rally stay top of mind for stock investors next week3 Hours AgoCNBC.com
Josh Brown buys more PfizerMay 2, 2024CNBC.com
Stocks making the biggest moves midday: Super Micro Computer, Starbucks and moreMay 1, 2024CNBC.com
Stocks making the biggest moves premarket: Pfizer, CVS, Amazon, Starbucks and moreMay 1, 2024CNBC.com
Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid salesMay 1, 2024CNBC.com

Content From Our Affiliates

Pfizer (PFE) Announces Q2 Dividend: Read On for Important Dates13 Hours AgoTipRanks
Analysts Conflicted on These Healthcare Names: InMode (INMD) and Pfizer (PFE)May 2, 2024TipRanks
Pfizer Exceeds Q1 Expectations with Strong Earnings and Raises 2024 Guidance: A Buy Rating by Evan SeigermanMay 2, 2024TipRanks
Analysts Have Conflicting Sentiments on These Healthcare Companies: Pfizer (PFE), Sagimet Biosciences, Inc. Class A (SGMT) and Alkermes (ALKS)May 2, 2024TipRanks
Pfizer’s Mixed Financial Signals: A Delicate Balance Between Growth and UncertaintyMay 2, 2024TipRanks

Profile

Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology...

Albert Bourla Ph.D.

Chairman of the Board, Chief Executive Officer

David Denton

Executive Vice President, Chief Financial Officer

Alexandre De Germay

Executive Vice President, Chief International Commercial Officer

Aamir Malik

Executive Vice President, Chief US Commercial Officer

Lidia Fonseca Ph.D.

Executive Vice President, Chief Digital and Technology Officer

Address

66 HUDSON BOULEVARD EAST

New York, NY

10001-2192

United States

https://www.pfizer.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
SNY Sanofi SA	49.01	-0.45	-0.91%
RHHBY Roche Holding AG	29.83	+0.57	+1.95%
NVS Novartis AG	97.27	-0.07	-0.07%
AMGN Amgen Inc	311.29	+32.90	+11.82%
BMY Bristol-Myers Squibb Co	43.99	+0.29	+0.66%